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PEX4Trypanosomatids contain peroxisome-like organelles called glycosomes. Peroxisomal biogenesis involves a cyto-
solic receptor, PEX5, which, after its insertion into the organellar membrane, delivers proteins to the matrix. In
yeasts andmammalian cells, transient PEX5 monoubiquitination at the membrane serves as the signal for its re-
trieval from the organelle for re-use. When its recycling is impaired, PEX5 is polyubiquitinated for proteasomal
degradation. Stably monoubiquitinated TbPEX5 was detected in cytosolic fractions of Trypanosoma brucei, indic-
ative for its role as physiological intermediate in receptor recycling. This modiﬁcation's resistance to
dithiothreitol suggests ubiquitin conjugation of a lysine residue. T. brucei PEX4, the functional homologue of
the ubiquitin-conjugating (UBC) enzyme responsible for PEX5 monoubiquitination in yeast, was identiﬁed. It is
associated with the cytosolic face of the glycosomal membrane, probably anchored by an identiﬁed putative
TbPEX22. The involvement of TbPEX4 in TbPEX5 ubiquitination was demonstrated using procyclic ΔPEX4 try-
panosomes. Surprisingly, glycosomal matrix protein import was only mildly affected in this mutant. Since
other UBC homologues were upregulated, it might be possible that these have partially rescued PEX4's function
in PEX5 ubiquitination. In addition, the altered expression of UBCs, notably of candidates involved in cell-cycle
control, could be responsible for observed morphological and motility defects of the ΔPEX4mutant.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Human African trypanosomiasis is an infectious disease caused by
the parasitic protist Trypanosoma brucei and transmitted by bites of
tsetse ﬂies. T. brucei belongs to the Kinetoplastea clade and the
Trypanosomatidae family. This group also includes Trypanosoma cruzi,
the causative agent of Chagas disease in Latin America, and Leishmania
specieswhich are responsible for several forms of leishmaniasis in trop-
ical and subtropical areas of the world [1–3].
The T. brucei life cycle involves several successive developmental
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ights reserved.extracellularly in the mammalian host, where its main form is the pro-
liferative so-called long-slender bloodstream form and in the insect,
where procyclic forms are the replicating stage in the ﬂy's midgut.
This differentiation, which involves physiological, morphological and
metabolic remodelling, allows the parasite to adapt to the different en-
vironments [4,5].
One of the unique features that distinguish members of the
kinetoplastids from other eukaryotes is the metabolic compartmen-
talisation of the majority of glycolytic enzymes and some other path-
ways of core metabolism within organelles called glycosomes [6–8].
Remarkably, correct compartmentalisation of glycolysis in glycosomes
of the bloodstream form of T. brucei is absolutely essential for survival
of the parasites [9,10].
Glycosomes are microbodies that belong to the organelle family of
peroxisomes, together with the peroxisomes found in representatives
of all eukaryotic lineages. These organelles are bounded by a single
phospholipid bilayer membrane and do not contain any detectable
DNA. Peroxisomal and glycosomal matrix and membrane proteins are
synthesised in the cytosol and post-translationally imported into the
organelles. The formation of these organelles involves different proteins
(so far a non-redundant set of 33 proteins have been identiﬁed in
different organisms) commonly named ‘peroxins’ (abbreviated PEX),
which accomplish the different steps of the process: peroxisome
3077M. Gualdrón-López et al. / Biochimica et Biophysica Acta 1833 (2013) 3076–3092membrane formation, import of peroxisomal matrix proteins and per-
oxisome proliferation [11–13].
Peroxisomal matrix protein import is a multistep process that in-
volves successive interactions between several peroxins in the cytosol
and at the peroxisomal membrane. The matrix proteins are targeted
to the organelles through their peroxisomal-targeting signals: PTS1,
consisting of the motif SKL or physicochemically conserved variants of
this tripeptide, with also contributions by adjacent residues, more
precisely a dodecamer sequence, located at the extreme C-terminus
of the great majority of matrix proteins [14]; PTS2 is a nonapeptide
(R/K)(L/V/I/Q/)xx(L/V/I/H/Q)(L/S/G/A/K)X(H/Q)(L/A/F) near the N-
terminus of a smaller subset of matrix proteins [13,15,16]. The matrix
proteins are recognised in the cytosol through their targeting signals
PTS1 or PTS2 by different receptors, PEX5 and PEX7, respectively.
PEX5 is a predominantly cytosolic protein that possesses two domains:
a C-terminal domain composed of 6–7 tetratricopeptide repeat (TPR)
motifs which interact with the PTS1 of the cargo, and a structurally
disordered N-terminal domain that functions in the receptor's docking,
at the organelle's membrane, through its conserved pentapeptide
(WxxxF/Y) repeat motifs, and in the receptor's recycling (see below).
PEX7 is also a cytosolic protein that becomes transiently internalised in-
side the peroxisomes [17,18] belonging to the WD protein family. For
the PTS2-protein import, it requires species-speciﬁc auxiliary proteins
also known as co-receptors: PEX18 and PEX21 in Saccharomyces
cerevisiae, PEX20 in Yarrowia lipolytica, Pichia pastoris, Hansenula
polymorpha and Neurospora crassa or a longer splice variant of the PTS1
receptor PEX5 in plants and mammals. The co-receptors form a ternary
complex with the cargo-loaded PEX7 in the cytosol and direct the com-
plex to the peroxisomal membrane [19]. A small fraction of proteins
that lack canonical PTS1 and 2 motifs may be imported through either
their association with PTS-containing proteins (“piggy backing”) or via
the binding to the N-terminal region of PEX5 (non-PTS import) [20].
The next step in matrix protein import is the association of the re-
ceptor–cargo complex, formed in the cytosol, with the peroxisomal
membrane. A docking subcomplex minimally composed of PEX14,
PEX13 and in S. cerevisiae also PEX17, is responsible for this step [21].
The docking subcomplex has been shown to physically associate with
a subcomplex of three RING-ﬁnger proteins, PEX2-PEX10-PEX12, in
order to form an import-competent complex, called the importomer
[13,15]. The docking and RING-ﬁnger subcomplexes are associated in
a PEX8 and PEX3-dependent manner in S. cerevisiae and P. pastoris, re-
spectively [22].
Peroxisomes are able to import folded proteins and also large oligo-
meric proteins into the peroxisomal matrix [23,24]. Recently, Meinecke
et al. [25] demonstrated that themembrane-associated import receptor
PEX5 from S. cerevisiae together with the docking-complex protein
PEX14 forms a dynamic channel that is opened to a diameter up to
9 nM upon docking of the cytosolic receptor–cargo complex. This dis-
covery explains how peroxisomes are able to import completely folded
and even oligomeric proteins of different sizes and illustrates the ex-
tremely important, multiple roles of PEX5 in the peroxisomal matrix
protein import process.
The next step inmatrix protein import is the cargo release in theper-
oxisomalmatrix, themechanism of which is poorly understood. Several
lines of evidence indicate a possible function of PEX8 in the dissociation
of cargo proteins from the PEX5–cargo complex; however, this issue re-
mains to be solved [16]. After the cargo release, the two receptors, PEX5
and PEX7, must be retrieved from the peroxisomes. Whereas PEX7 is
fully internalised into the matrix [18], PEX5 does not enter the lumen
with its cargo, but seems to release it while remaining inserted in the
membrane. PEX5 is thus a cycling protein that translocates to the perox-
isomal membrane fromwhere it is recycled to the cytosol [26]. Themo-
lecular machinery that is involved in this process was deﬁned as the
exportomer [16]. It comprises two cytosolic AAA+-ATPases, PEX1 and
PEX6, which are anchored to the peroxisomal membrane through
PEX15 in yeasts or PEX26 in mammalian cells, and which have beenidentiﬁed as the mechanoenzymes responsible for the removal of
PEX5 from the peroxisomalmembrane [27]. Also part of the exportomer
is a member of the E2 ubiquitin-conjugating enzyme family, a function
performed in yeasts and plants by PEX4 togetherwith itsmembrane an-
chor protein PEX22 [28–30]. Inmammalian cells, this function is accom-
plished by the cytosolic ubiquitin-conjugating enzymes UbcH5a/b/c
[31]. Additionally involved in the receptor recycling are the RING-ﬁnger
peroxins which have E3-ubiquitin ligase activity [32].
Unlike the docking event, which is ATP independent, the receptor
recycling requires the free energy from the hydrolysis of ATP, both by
the AAA+-ATPases and for the activation of ubiquitin. Recently, it has
beenproved that theATP-dependence of theubiquitination-mediated ex-
port of S. cerevisiae PEX18, via themechanistic linkage, drives the translo-
cation of the PEX7 receptor-bound cargo into the matrix [33], supporting
the export driven protein import model proposed by Schliebs et al. [34].
In yeast PEX5 is mono- or polyubiquitinated at the peroxisomal
membrane. The monoubiquitination of the receptor serves as the signal
for its recycling and depends on the concerted action of the peroxisomal
membrane-bound PEX4 and PEX12, which ubiquitinate PEX5 at a con-
served cysteine residue (Cys6) located in its N-terminal part. The
polyubiquitination has been demonstrated to occur as a quality control
mechanism that serves to signal the removal of not properly recycled
receptor molecules. This type of ubiquitination depends on the redun-
dant activities of the cytosolic ubiquitin-conjugating enzymes UBC4/5/
1 and membrane-bound PEX2 and occurs at different lysine residues
located also in the N-terminal part of the protein (Lys18 and Lys24 in
S. cerevisiae and Lys 21 inH. polymorpha) [28,29,32,35–37]. Importantly,
in S. cerevisiae the co-receptor PEX18 has been proved to be also
monoubiquitinated at a conserved cysteine residue (Cys6) as a signal
for its recycling and polyubiquitinated at lysine residues (Lys13 and
Lys20) for its proteasome-dependent degradation [33]. Very recently,
it has been shown that the P. pastoris co-receptor PEX20 is also mono-
or diubiquitinated (Cys8) and polyubiquitinated (Lys19) in a PEX4
and PEX4–PEX7 dependent manner, respectively, providing new roles
for PEX4 in the ubiquitination cascade of the PTS2 import pathway [38].
PEX5 in mammalian cells, as with its counterpart in yeast, is also
monoubiquitinated at the peroxisomal membrane at a well conserved
cysteine residue (Cys11) [39]. However, the ubiquitin-conjugating en-
zyme involved in this modiﬁcation is the cytosolic broad range UbcH5a/
b/c [31]. It was recently proved that mammalian PEX10 is necessary for
PEX5 ubiquitination as well [40]. Interestingly, in mammalian cells two
different monoubiquitinated PEX5 species were detected in distinct cel-
lular locations. While the cysteine-monoubiquitinated [dithiothreitol
(DTT) sensitive] form of PEX5 was exclusively detected in the organellar
fraction of mammalian cells, another monoubiquitinated form (DTT re-
sistant), for which no function has yet been ascribed, was located in the
cytosol [40,41].
In trypanosomes, several of the peroxins involved in the glycosomal
matrix protein import have been identiﬁed and characterised. These in-
clude TbPEX2, TbPEX5, TbPEX6, TbPEX7, TbPEX10, TbPEX12, TbPEX13
(two different isoforms, TbPEX13.1 and TbPEX13.2) and TbPEX14. All
these peroxins are essential for glycosome biogenesis and therefore for
the survival of the parasites (reviewed in [9,10,42]). Nevertheless, few
data are available yet about the mechanism of the import process and
how some of these peroxins operate in TbPEX5 recycling. In this paper
we provide the ﬁrst experimental evidence of TbPEX5 ubiquitination
and present the identiﬁcation and functional characterisation of the
T. brucei orthologue of the peroxisomal ubiquitin-conjugating enzyme
TbPEX4.
2. Materials and methods
2.1. Parasite cultures, transfections and cell growth measurements
Monomorphic bloodstream and procyclic-form T. brucei strain Lister
427 (hereafter called T. brucei 427), cell lines 449 [43] that were used in
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repressor gene from the chromosomally integrated plasmid pHD449,
also endowing phleomycin resistance. This cell line is metabolically in-
distinguishable from the wild type. Bloodstream forms were cultured
in HMI-9 medium containing 20% heat-inactivated foetal calf serum
(Gibco) and 0.18 μg/ml phleomycin (Cayla) at 37 °C under water-
saturated air with 5% CO2. Procyclic trypanosomes were grown in
SDM79 medium [44] supplemented with 12% foetal calf serum and
0.5 μg/ml phleomycin at 28 °C under water-saturated air with 5% CO2.
Cultures were always harvested in the exponential growth phase, i.e.,
at densities lower than 1 × 106 cells/ml for bloodstream forms and
1 × 107 cells/ml for procyclic cells, by centrifugation at 700 ×g for
10 min. The method used for transfection of bloodstream and procyclic-
form trypanosomes has previously been described [45]. For cell growth
measurements cultures of 1 ml were started at 2 × 105 cells/ml (blood-
stream form) and 2 × 106 cells/ml (procyclic form). Motile cells were
daily counted in a Bürker–Türk (Merck) cell counting grid (0.1 mm in
depth). After dilution down to the initial cell density, cellswere recounted
similarly. Accumulative growth curves were constructed by plotting the
log10 of the product of cell density (cells/ml) and total dilution as a func-
tion of time.
2.2. Preparation of DNA constructs and cloning procedures
Standard methodologies in molecular biology were carried out es-
sentially according to Sambrook et al. [46]. Chemicals and enzymes
were obtained from Fermentas, Roche Diagnostics and Promega Corpo-
ration. The sequences of primers used are available in Table S1 of the
Supplementary data ﬁle. All constructs were checked by sequencing.
Formyc-ubiquitin cloning the full-length geneof onemonoubiquitin
(derived from the putative polyubiquitin gene; TriTrypDB (http://
tritrypdb.org) accession code Tb11.01.1680) was ampliﬁed by PCR
from T. brucei 427 genomic DNA using the set of primers MycUbi for-
ward and reverse. The PCR-ampliﬁed fragment digested with HindIII–
BamHI was cloned using the trypanosome-speciﬁc tetracycline-induc-
ible expression vector pHD1701 (a gift from Dr Frank Voncken),
which directs the synthesis of an N-terminal 2×-myc-tagged fusion
protein.
All TbPEX4 constructs described herewere derived from the T. brucei
gene with accession code Tb927.8.920. For bacterial expression, the full
open‐reading frame (ORF) of TbPEX4 (FL) was ampliﬁed by PCR from
genomic DNA of T. brucei 427 using the primers TbPEX4FL forward
and reverse. The ampliﬁed TbPEX4FL genewasﬁrst inserted in the clon-
ing vector pJET1.2 (Thermo Fisher Scientiﬁc) and from there transferred
to the bacterial expression vector pET28a (Novagen) between the re-
striction sites NdeI and BamHI. This vector directs the expression of an
N-terminally (His)6-tagged recombinant protein under the control of
the Lac promoter.
To express in trypanosomes an N-terminally green-ﬂuorescent pro-
tein (GFP) tagged-TbPEX4 protein, the TbPEX4 full-length genewas am-
pliﬁed by PCR from T. brucei 427 genomic DNA using the primers GFP-
TbPEX4FL forward and reverse. PCR ampliﬁed fragments were digested
with HindIII and BamHI and ligated in the trypanosome-speciﬁc vector
pGC1 containing already the GFP gene (previously prepared by the in-
sertion of the EGFP gene into the trypanosome-speciﬁc tetracycline-in-
ducible expression vector pHD1336 [47]).
A TbPEX4knock-out constructwas prepared as follows: a segment of
the 5′UTR region of the TbPEX4 locus from position−581 to−16 and a
segment of the 3′UTR region comprising the last 22 bp of the ORF of
TbPEX4 until position +592 were ampliﬁed by PCR from T. brucei 427
genomic DNA using the following sets of primers: 5′UTRKOTbPEX4 for-
ward and reverse, 3′UTRKOTbPEX4 forward and reverse. Each fragment
was individually cloned using the pGEMT Easy Vector (Promega Corpo-
ration) to create the plasmids pGEMT-5′UTRTbPEX4 and pGEMT-3′
UTRTbPEX4, respectively. Subsequently, the 3′UTRTbPEX4 fragment
was liberated from the vector and subcloned after ligating it in thepGEMT-5′UTRKOTbPEX4 vector between the restriction enzymes
EcoRI and XbaI to generate pGEMT5′-3′UTRKOTbPEX4. The puromycin
resistance gene (Streptomyces alboniger puromycin N-acetyltransferase
gene) and blasticidin resistance gene (Aspergillus terreus blasticidin
S deaminase gene) were excised from plasmid pGEMT-puro and
pGEMT-bla (gifts from Dr Frédéric Bringaud) using the restriction en-
zymes XbaI and XhoI and each was individually ligated in pGEMT5′-3′
UTRKOTbPEX4 to generate pGEMT5′-PURO-3′UTRKOTbPEX4 and
pGEMT5′-BLA-3′UTRKOtbPEX4. These two plasmids were then digested
with the restriction enzyme HpaI to liberate the fragments TbPEX4-5′-
PURO-3′UTR and TbPEX4-5′-BLA-3′UTR containing the corresponding
selection markers ﬂanked by 500 bp of the UTR region of the TbPEX4
locus. These DNA fragments were sequentially used to transfect T. brucei
procyclic and bloodstream forms and replace each allele of the PEX4
gene by homologous recombination by the respective antibiotic resis-
tance markers.
A GFP-PTS1 trypanosome expression plasmid was constructed by
PCR ampliﬁcation of the gene coding for GFP with at its C-terminus
fused a PTS1 (SKL) from the yeast expression vector pEW88 (a gift
from Dr Ben Distel) using primers GFP-SKL forward and reverse. The
ampliﬁed PCR fragment was digested with HindIII and BamHI and ligat-
ed to the trypanosome-speciﬁc tetracycline-inducible expression
vectors pHD1336 and pHD677 (gifts from Prof. Christine Clayton).
2.3. Genome integration analysis
Total genomic DNA was extracted from 5 × 107 cells using the
Magnesyl KF genomic system (Promega Corporation) and the Kingﬁsh-
er Labsystem (Thermo Fisher Scientiﬁc). Brieﬂy, after selection of posi-
tive clones (resistant to the respective antibiotic markers) of procyclic-
and bloodstream-form T. brucei cells transfected with the relevant
plasmids containing knock-out constructs, they were analysed to con-
ﬁrm the correct integration of the corresponding gene(s) by PCR from
genomic DNA. The criteria to assess the integration of TbPEX4 knock-
out constructswere based on a PCR reaction performedwith the follow-
ing sets of primers: TbPEX4-RTPCR forward and reverse, Blast forward
and reverse, Puro forward and reverse, Tubulin forward and reverse.
The negative result of a non-ampliﬁcation of the TbPEX4 gene and the
simultaneous positive results in ampliﬁcation of the blasticidin and pu-
romycin resistance marker genes were used as evidence for successful
double gene knock-out. This was only achieved for procyclic trypano-
somes; despite repeated attempts, no bloodstream-form null mutant
was obtained, suggesting that it would have a lethal phenotype.
2.4. RT-PCR and qPCR
Total RNAwas isolated from5 × 107 cells using the SV total RNA iso-
lation system (Promega Corporation). After quantiﬁcation, 2 μg of total
RNA was used to synthesise cDNA using the RevertAid™ H Minus First
Strand cDNA Synthesis Kit (Thermo Fisher Scientiﬁc) following the
manufacturer's instructions. Total cDNA was diluted 4-fold and used
as a template for PCR ampliﬁcation using the same primer set for the
genomic integration analysis. Fixed volumes were loaded into slots of
2% agarose gels and stained with ethidium bromide. For qPCR analysis
of the ΔPEX4 cell line, cDNA was not diluted after synthesis and used
for a qPCR reaction with 10 μl of KAPA SYBR® FAST Bio-Rad iCycler™
qPCR Master Mix (Sopachem, Kapa Biosystems, Eke, Belgium) and
10 pmol of each primer. A single denaturing step at 94 °C for 300 s
was followed by 40 cycles: 94 °C for 30 s and 60 °C for 3 s. For quanti-
ﬁcation, the copy number of each mRNAwas normalised to the tubulin
mRNA copy number. Sets of forward and reverse primers were used for
the following genes: TbPEX4-RTPCR, Tb927.5.1000, Tb11.01.5510,
Tb927.7.2540, Tb927.8.6090, Tb927.2.3720, Tb09.211.0050, Tb927.
4.3460, Tb11.01.5790, Tb927.4.2710, Tb927.4.3190 and Tubulin, as
speciﬁed in Table S1.
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Immunoblotting was performed according to a standard procedure
[48] with slight modiﬁcations. Brieﬂy, proteins were size separated by
SDS-PAGEand then transferred to anitrocellulosemembrane (Amersham
Biosciences, Inc.) using a wet transfer tank (Hoefer Instruments). Non-
speciﬁc binding of antibodies to the membrane was prevented by
blocking in PBS supplementedwith 5% dried low-fat milk for 1 h. Incuba-
tion with primary antibodies was done in PBS supplemented with 1%
dried low-fatmilk overnight at room temperature.Membraneswere sub-
sequently washed by consecutive 10 min incubations in PBS (2×), PBS
supplemented with 0.05% NP-40 (1×) and PBS (2×). Incubation with
the secondary antibody was done in PBS supplemented with 1% dried
low-fat milk for 1 h at room temperature. For detection of the following
proteins, polyclonal antisera raised in rabbits were used at the indicated
dilutions: TbPEX5 (1:20,000), TbPEX4 (1:4000), TbPEX4 peptide based
(afﬁnity puriﬁed) (1:300), human ubiquitin (Santa Cruz Biotechnology,
Inc.) (1:300), TbPEX11 (1:2500), TbEnolase (1:150,000), TbAldolase
(1:200,000), cytosolic glyceraldehyde-3-phosphate dehydrogenase
(TbcGAPDH) (1:10,000), hexokinase (TbHXK) (1:100,000). Furthermore,
a mouse monoclonal antibody against heat-shock protein 60 (TbHSP60)
(1:100) was used (courtesy of Dr Frédéric Bringaud). The secondary anti-
bodies, anti-rabbit IgG and anti-mouse IgG conjugated to horseradish per-
oxidase (Rockland Immunochemicals, Inc.) were diluted 1:10,000 and
visualisedwith the ECLWestern Blotting System, a luminol-based system
(Amersham Biosciences, Inc.).
2.6. Immunoﬂuorescence
Immunoﬂuorescence analysis of trypanosomes was performed as
described by Galland et al. [49], with the following modiﬁcations.
Procyclic- and bloodstream-form trypanosomes (1 × 107 cells) were
centrifuged at 918 ×g in a T15A61 VWR rotor for 5 min at 4 °C and
washed twice in ice-cold PBS. Cell ﬁxation was done with 4% formalde-
hyde in PBS for 10 min at room temperature in a rotating device follow-
ed by a permeabilisation step involving treatmentwith 1% Triton X-100
for 15 min. Finally cells were incubated for 1 h with PBS containing
0.5 M glycine and then washed once in ice-cold PBS. After applying a
suspension of trypanosomes on poly-L-lysine coated microscope slides
and drying during 1 h at room temperature, unspeciﬁc antibody bind-
ing was blocked by incubation in PBS containing 5% BSA for 45 min at
37 °C, followed by incubationwith primary antiserum in PBS containing
2% BSA at the following dilutions: mouse monoclonal anti-T. brucei
triosephosphate isomerase (TbTPI) (1:5000), rabbit polyclonal
TbAldolase (1:1500) and anti-T. brucei glycosomal GAPDH (TbgGAPDH)
(1:5000). After extensive washes with PBS, the slides were incubated
for 45 min at 37 °C with ﬂuorescein-conjugated secondary antibodies
(Alexa Fluor 488 anti-mouse IgG, Alexa Fluor 488 anti-rabbit, Alexa
568 anti-mouse IgG and Alexa 568 anti-rabbit IgG) (Molecular Probes,
Invitrogen Corporation) in PBS containing 2% of BSA at a 1:1000 dilu-
tion. After washes with PBS, cells were incubated with 4′,6-diamidino-
2-phenylindole (DAPI) (1:500) in PBS for 30 min at room temperature
followed by washes in PBS. The preparations were ﬁnally mounted in
Dako (Dako North America, Inc.) and visualised using a Zeiss Axiovert
200 inverted ﬂuorescence microscope coupled to an MRC-1024 confo-
cal scanning laser imaging system (Bio-Rad Laboratories, Inc.). Digital
images were captured using the software AxioVision 4.8.2 (Zeiss).
Images to be analysed were imported in AxioVision (4.8.2; Zeiss,
Germany).
2.7. Immunoprecipitation
Native TbPEX5 was immunoprecipitated under denaturing condi-
tions from T. brucei wild-type procyclic cells as described in Leung
et al. [50].2.8. Differential centrifugation
A total of 8 × 109 exponentially growing wild-type bloodstream
(5 × 105 cells/ml) and procyclic (5 × 106 cells/ml) trypanosomes
were collected, centrifuged at 680 ×g in a SLA-3000 Sorvall rotor for
15 min at 4 °C and washed twice in isotonic STE buffer (250 mM su-
crose, 25 mM Tris–HCl, pH 7.4, 1 mM EDTA). Cells were homogenised
(N95%, as microscopically checked) in a pre-chilled mortar with carbo-
rundum powder as described by Opperdoes and Borst [6]. Differential
centrifugation was performed as described by Verplaetse et al. [51].
Equal amounts of protein of each fraction were analysed by SDS-PAGE
followed by Western blotting.
2.9. Isopycnic centrifugation
Exponentially growing procyclic-form trypanosomes (1.5 l;
5 × 106 cells/ml) were centrifuged at 680 ×g in a SLA-3000 Sorvall rotor
for 15 min at 4 °C, washed once with 150 ml of TEDS buffer (25 mM
Tris–HCl, pH 7.8, 1 mM EDTA, 1 mM DTT, 250 mM sucrose) followed by
a second wash with 50 ml of the same buffer. Cells were homogenised
(microscopically checked) in a pre-chilled mortar with carborundum
powder as described previously [6]. Differential centrifugation was done
as described by Verplaetse et al. [51] to prepare a large granular fraction
enriched in mitochondria and glycosomes. 2.5 ml of this large granular
fraction was loaded on the top of a preformed linear 20–40% (v/v)
Optiprep density gradient (33 ml) mounted on top of a 3.5 ml 50% (v/v)
Optiprep cushion according to the manufacturer's instruction (Optiprep
application sheet S09, Axis-shield). The gradients were centrifuged at
4 °C in a VTi-50 vertical rotor (Beckman Coulter, Inc.) at 100,000 ×g
overnight, using the slow acceleration and deceleration modes. Fractions
of 1 ml were collected from the bottom of the tube using an automatic
fraction collector. Protein concentrations were determined by Bradford
method. Proteins present in 300 μl of each fraction were precipitated
with trichloroacetic acid and cold acetone according to standard
procedures. Western blot analysis of each fraction was performed as pre-
viously explained. The diffraction index was measured for each fraction
and the respective densities were then calculated from the indices
2.10. Protease protection assay
Protein protection assays were performed using a method previous-
ly described by Igoillo-Esteve et al. [52].
2.11. Proteasome inhibition and cellular fractionation
The following exponentially growing T. brucei cells were treated for
6 h with the proteasome inhibitor lactacystin (Sigma-Aldrich Corpora-
tion) at a concentration of 1 μM, that has proved to be effective in try-
panosomes by Böhme and Cross [53]: wild-type bloodstream
(5 × 105 cells/ml) (100 ml) and procyclic (5 × 106 cells/ml) forms,
the procyclic Myc-Ub cell line as well as the procyclic ΔPEX4 cell line
(each 50 ml). Subsequently, the cells were centrifuged at 700 ×g in an
HS-4 Sorvall rotor and washed once in STE buffer. Cell pellets were
resuspended in aminimal volume of STE buffer (300 μl) and the protein
content in each cell suspensionwas quantiﬁed by the Bradford method.
Aliquots of cells containing 300 μg of proteinweremixedwith HBSS-IP-
NEM [Hank's buffered salt solution supplementedwith a cocktail of pro-
tease inhibitors (Fermentas, Inc.) and 20 mM of N-ethylmaleimide
(NEM)] to adjust each volume to 300 μl. Cells were treated with
0.1 mg digitonin/mg of protein for 4 min at room temperature and im-
mediately centrifuged at 20,000 ×g in a T15A61 VWR rotor for 2 min at
4 °C. 280 μl of the supernatant (cytosolic fraction) was taken. The
organellar pellet was washed once in HSSB-IP-NEM buffer, centrifuged
at 20,000 ×g for 2 min at 4 °C and ﬁnally resuspended in 150 μl of
HSSB-IP-NEM buffer. Supernatant (135 μl) and pellet samples
(67.5 μl) were diluted for SDS-PAGE in 4× Laemmli buffer containing
3080 M. Gualdrón-López et al. / Biochimica et Biophysica Acta 1833 (2013) 3076–3092or not DTT (25 mM). Samples containing DTT were boiled at 100 °C for
5 min,while sampleswithout DTTwere heated at 56 °C for 10 min. The
proteins in 60 μl of the preparations were resolved by SDS-PAGE and
analysed by Western blotting.130
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3081M. Gualdrón-López et al. / Biochimica et Biophysica Acta 1833 (2013) 3076–3092times in PBS-Ca/Mg (PBS, pH 7.0, with 3.6 mM CaCl2 and 3.0 mM
MgCl2) at room temperature and ﬁxed in successively 0.1 M cacodylate
buffer with 0.1% glutaraldehyde for 30 min, 1% glutaraldehyde for
30 min and ﬁnally 2% glutaraldehyde overnight. After three wash
steps in 0.1 M cacodylate buffer, post-ﬁxation was performed with 1%
OsO4 in cacodylate buffer for 4 h. Subsequently, the samples were
washed extensively in this buffer for 30 min, then 6 × 10 min in
water and ﬁnally dehydrated by overnight incubation in 70% ethanol.
The next day samples were further dehydrated in a graded series of
ethanol, critical point dried, mounted and sputter coated with a
10 nm gold layer. Samples were then examined in a CM12 electron mi-
croscope (Philips) at 80 kV by use of the secondary electron detector
(scanning mode). The cell size was estimated by the calculation of the
cell body projected area of 30 cells from scanned images of the wild-
type and ΔPEX4 cells using the AxioVision software (4.8.1; Zeiss,
Germany). Values obtained were analysed by a “Kolmogorov–Smirnov
two sample statistical test”.
3. Results
3.1. PEX5 is ubiquitinated in wild-type bloodstream and procyclic-form
T. brucei
To explore the possibility that PEX5 in T. brucei is ubiquitinated, like
its counterparts in yeast and mammalian cells, Western blot analysis of
wild-type bloodstream- and procyclic-form cells was performed. In addi-
tion, some of the cells were, prior to this analysis, treated with the
proteasome inhibitor lactacystin. The purpose of this treatmentwas to in-
vestigate if inhibition of proteasome activity would lead to accumulation
of polyubiquitinated forms of TbPEX5, as a response to failure of the
quality-control system involved in the disposal of non-recycled mole-
cules of PEX5, as occurs in yeast cells. Western blot analysis showed
that the 100 kDa native form of TbPEX5was highly abundant in the cyto-
solic fraction (deﬁned by the cytosolic marker enolase), while a minor
part was associated with the organellar fraction containing the
glycosomal marker aldolase (Fig. 1A). Note the presence of a 70 kDa
TbPEX5 species, that has previously been identiﬁed in our laboratory as
a proteolytically processed form [54]. Importantly, in the conditions test-
ed, the TbPEX5 antiserum also detected a slowermigrating form of about
110 kDa exclusively in the cytosolic fraction of both bloodstream and
procyclic cells. Based on its molecular weight, we hypothesise that this
newly detected TbPEX5 species could represent a monoubiquitinated
form of the receptor. Surprisingly, this additional band was absent from
the organellar fraction. It should be mentioned that a 130 kDa band
was also detected by TbPEX5 antiserum in the organellar fraction,
which at face value might be interpreted as a polyubiquitinated form of
TbPEX5. However, later experiments (discussed below) showed that
the detection of this band should most likely be attributed to cross-
reactivity of the antiserum with a unidentiﬁed, unrelated protein. The
treatment with lactacystin did not affect the abundance of the additional
cytosolic 110 kDa TbPEX5 species, indicating no role of proteasome
inhibition in the stabilisation of this modiﬁed TbPEX5 form. The intensity
of this new band was not affected either by the presence of DTT, atFig. 1. (A). A slower migrating TbPEX5 form is present in T. brucei wild-type cells. Wild-type b
proteasome inhibitor lactacystin for 6 h. Cytosolic and organellar fractions were prepared af
NEM followed by centrifugation. Protein samples were prepared in Laemmli buffer containing
form of TbPEX5 (Ub-PEX5)was exclusively detected in cytosolic fractions, irrespective of the pr
and aldolasewere used asmarkers for cytosolic and organellar fractions respectively. (B). A seco
somes ofwild-type procyclic-form (PF) and a PFMyc-Ub cell line expressing 2×-myc-ubiquitin
was detected by the TbPEX5 antiserum; it corresponds to Myc-Ub-TbPEX5 and is exclusively f
independent. The * indicates an in vitro proteolytically processed form of TbPEX5. Note that sam
due to incomplete denaturation of proteins. (C). The slowermigrating form of TbPEX5detected
T. bruceiwild-type procyclic-form cells. Western blot analysis was performedwith the elution f
TbPEX5was detected by the anti-ubiquitin antiserum proving that TbPEX5 is ubiquitinated inw
cut to incubate the different parts separately with the respective antisera.concentrations up to 25 mM, suggesting that the ubiquitin is attached
to a lysine residue. The sequences of the N-terminal half of PEX5s are
highly variable (Supplementary data, Fig. S1), but importantly in all
mammalian and yeast species they contain a cysteine residue that,
under physiological conditions, is a target of monoubiquitination.
TbPEX5 has also a cysteine (Cys3) in a similar region as its counterparts
in other species. Thus, one might expect that, if TbPEX5
monoubiquitination occurs, it would involve this cysteine residue. Future
investigation should provide a deﬁnitive assignment of the TbPEX5
monoubiquitination at Cys3 or a Lys residue.
As a strategy to prove the ubiquitinated nature of the newly detect-
ed form of TbPEX5, a procyclic T. brucei cell line was created that ex-
presses an N-terminally 2×-myc-tagged-ubiquitin protein (with a
predicted additional molecular weight of 12.5 kDa) under the control
of a tetracycline-inducible promoter. The wild-type and myc-tagged
ubiquitin-expressing procyclic cell lines were treated with lactacystin
for 6 h, followed by a cell fractionation performed similarly as described
above, but in the presence or absence of the nonspeciﬁc sulfhydryl
alkylating agent NEM that is known to inhibit many Cys-containing en-
zymes. Since NEM also affects ubiquitin-dependent isopeptidases, we
aimed to see in this manner if inhibition of deubiquitinating (DUB) en-
zymes affects the presence of the additionally detected TbPEX5 forms.
Inhibition of DUB enzymes by high concentrations of NEM is a standard
method previously used to study monoubiquitination of PEX5 in cells
from different organisms [39,55] and the PEX7 co-receptors PEX18
and PEX20 in yeasts [33,38]. Western blot analysis showed in the
myc-ubiquitin expressing procyclic cells a new, slower migrating form
of about 115 kDa, detectable by the TbPEX5 antiserum, present in the
cytosolic fractions, in addition to the 110 kDa form also detected in
the wild-type cells (Fig. 1B). By including the proteasome inhibitor
lactacystin, we conﬁrmed once more that addition of this drug did not
lead to stabilisation of the slower migrating forms of TbPEX5 in the
wild-type and myc-ubiquitin expressing cells, suggesting that these
forms correspond to stable species of TbPEX5 present in the cell. Impor-
tantly, this ﬁgure shows that the presence or absence of NEM during
fractionation did not lead to a change in the abundance of the slower
migrating forms of TbPEX5, proving that inhibition of deubiquitinating
enzymes is not required for the detection of these modiﬁed PEX5
forms in trypanosomes, different from the situation in other organisms.
Additionally, it should be mentioned that the 130 kDa band, exclu-
sively observed in the organellar fraction (Fig. 1), was not affected by
the expression of myc-ubiquitin (not shown), allowing us to discard
this band as a polyubiquitinated form of PEX5 and rather attribute it
to non-speciﬁc binding of the TbPEX5 antiserum to another protein.
As further proof that TbPEX5 is ubiquitinated we have immuno-
precipitated this receptor from wild-type procyclic cells and performed
Western blot analysis using commercially available antibodies against
human ubiquitin. Fig. 1C shows that the eluted fraction after immuno-
precipitation of TbPEX5 contains the native form (100 kDa) as well
as the slower migrating form of 110 kDa detectable with anti-
PEX5, although the latter was only detected as a very faint band.
When this sample was analysed with human ubiquitin antibodies,
the TbPEX5 band of 110 kDa was detected. It should be noted thatloodstream-form (Bf) and procyclic-form (Pf) cells were cultured in the presence of the
ter treatment of cells with 0.1 mg of digitonin/mg of protein in the presence of 20 mM
DTT or not and SDS-PAGE followed by Western blot was performed. A slower migrating
esence of DTT. The * indicates an in vitro proteolytically processed form of TbPEX5. Enolase
nd slowermigrating TbPEX5 form is detected upon expression ofmyc-ubiquitin. Trypano-
were treated as in panel A, but in the presence or absence of NEM. A slowermigrating band
ound in cytosolic fractions. Both slower migrating forms of TbPEX5 were lactacystin/NEM
plemigration was somewhat disturbed in lines 2, 4, 6 and 8 of the−DTT panel probably
inwild-type cells corresponds to ubiquitin-TbPEX5. TbPEX5was immunoprecipitated from
raction using antisera against human ubiquitin and TbPEX5. The slower migrating form of
ild-type cells. The horizontal dashed lines in panels A and B indicate where the blots were
3082 M. Gualdrón-López et al. / Biochimica et Biophysica Acta 1833 (2013) 3076–3092a band at approximately the same molecular weight as the native
TbPEX5 was also detected with the human ubiquitin antiserum.
However, it is likely that this should be attributed to a non-speciﬁc
reaction of the antiserum due to the very large amount of TbPEX5
protein present in the elution fraction.Aldolase
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To study in more detail the mechanism of TbPEX5 ubiquitination
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Fig. 3. TbPEX4 is associated with glycosomes at their cytosolic face. Intact glycosomes (la-
tency of 95%) present in a small granular fraction obtained by differential centrifugation
were used to perform a protease protection assay. CE: cellular extract, SG: small granular,
+P/+T: proteinase K/Triton X-100,−P/+T: no-proteinase K/Triton X-100,+P/−T: pro-
teinase K/no-Triton X-100,−P/−T: no-proteinase K/no-TritonX-100. TbPEX4was shown
to be susceptible to proteinase K proteolysiswhen glycosomeswere intact, similarly as the
AAA+-ATPase TbPEX6, TbPEX13 (SH3 domain), but in contrast to the glycosomal matrix
proteins FBPase and PFK which were protected under that condition. Notice that the
blot was cut to incubate the different parts separately with the respective antisera.
3083M. Gualdrón-López et al. / Biochimica et Biophysica Acta 1833 (2013) 3076–3092membrane-anchoring protein, PEX22. By homology searches we have
identiﬁed a likely candidate for each of these two peroxins in the
T. brucei genome database. The corresponding genes were cloned,
sequenced and expressed as recombinant proteins in E. coli. This work
and detailed in silico analyses of the sequences, as well as structure
modelling and yeast two-hybrid studies supporting the identity of
these proteins as the respective peroxins and their interaction, are
presented in the Supplementary data ﬁle, with Figs. S2 to S6.
3.3. TbPEX4 is an ubiquitin-conjugating enzyme present at the cytosolic
face of the glycosomal membrane
The localisation of the likely TbPEX4 candidatewas initially analysed
in subcellular fractions of wild-type bloodstream and procyclic-form
cells prepared by differential centrifugation. Thematrix protein aldolase
and membrane protein TbPEX11 were used as glycosomal markers. A
representative fractionation experiment performed with bloodstream-
form cells is shown in Fig. 2A. Aldolase and TbPEX11 are, as charac-
teristic for glycosomal proteins, mostly enriched in the small granu-
lar fraction and to a lesser extent in the large granular fraction. The
putative TbPEX4 protein was found, as expected, in the homogenate
and post-nuclear fraction, while after fractionation its distributionFig. 2. T. brucei PEX4 is associated with glycosomes. (A). TbPEX4 is present in a small granular fra
differential centrifugation and the fractions analysed by Western blotting. H: homogenate, CE: cel
microsomes, C: cytosol. TbPEX4 was identiﬁed in the small granular fraction enriched in the glyco
fugation is an enrichment procedure that still leaves someglycosomal protein aldolase and a consid
cut to incubate the different parts separatelywith the respective antisera. (B). TbPEX4 is present in
forms (PF) were puriﬁed by isopycnic centrifugation using the commercial Optiprepmedium. B1.
collected fractions. Antisera directed against the glycosomal matrix marker aldolase, glycosomal m
tochondria were examined with antibodies against TbHSP60. Notice that the blot was cut to incub
T. brucei glycosomes. An N-terminal GFP-TbPEX4 fusion protein was expressed in T. brucei bloodst
aldolase as glycosomal marker. GFP-TbPEX4 was shown to colocalise with aldolase suggesting itsproﬁle corresponds, for a major part, with a glycosomal localisation.
The presence of a relatively large amount of PEX4, and to a lesser extent
aldolase, in the nuclear fraction compared to PEX11 is considered an ar-
tefact (see theDiscussion section). Additional evidence for an association
of the putative TbPEX4 with glycosomes was obtained by equilibrium
centrifugation of procyclic (Fig. 2B; fractions 13–16) and bloodstream-
form trypanosomes (data not shown) using a linear Optiprep density
gradient. It is important to note that such isopycnic centrifugation of
peroxisomes and glycosomes leads unavoidably to the formation of so-
called “peroxisomal/glycosomal ghosts” which are formed as a result of
osmotic effects causing breakage of the organelles followed by resealing
or leakage ofmatrix content during the cell fractionation, generating less
dense vesicles which co-migrate with lighter fractions in the gradient
[56,57]. This phenomenon was evidenced by the presence of a minor
amount of aldolase and TbPEX11, together with TbPEX4, in other frac-
tions of the gradient, notably 23–28 (Fig. 2B).
As an alternative approach, the localisation of a GFP–TbPEX4 fusion
protein in bloodstream and procyclic wild-type cells was studied by
confocal immunoﬂuorescence microscopy. Stable cell lines were creat-
ed for the tetracycline-inducible expression of an N-terminally GFP-
tagged fusion protein as described in theMaterials andmethods section.
After induction of GFP-TbPEX4 expression, the subcellular localisation
of the ﬂuorescence signal was determined. Fig. 2C shows that the GFP-
TbPEX4 protein colocalised with the glycosomal matrix marker aldol-
ase, conﬁrming once more its glycosomal localisation.
Subsequently, we determined whether the protein is located in the
matrix or associated with the glycosomal membrane at its cytosolic
face. To that end, protease protection assayswere performed on puriﬁed
glycosomes obtained by differential centrifugation. Fig. 3 shows the re-
sults obtained with glycosomes from bloodstream-form T. brucei; the
same analysis was donewith glycosomes from procyclic cells with sim-
ilar results. TbPEX4 was efﬁciently degraded by proteinase K
irrespective of whether the glycosomal membrane was permeabilised
with Triton X-100 or not. This susceptibility indicates that TbPEX4 is as-
sociated with the side of the glycosomal membrane facing the cytosol,
as was also observed for TbPEX5, TbPEX6 and the C-terminal part (con-
taining the SH3 domain) of TbPEX13 that are known to be exposed to
the cytosol. The analysis of glycosomal matrix proteins such as
fructose-1,6-bisphosphatase (FBPase) and phosphofructokinase (PFK)
shows that glycosomes remained intact during the proteolytic treat-
ment. Other matrix markers such as aldolase and hexokinase showed
amore intriguing behaviour. Both enzymes seemed to be slightly sensi-
tive to proteinase K, resulting in a speciﬁc, short truncation of only a
fraction of these proteins. In addition, it was observed that such minor
proteolysis occurred also in the absence of the detergent, when the
glycosomal membrane was supposedly intact (data not shown). Since
the glycosome-rich fraction used in this experiment had a high latency
(based on hexokinase activity measurement) and both FBPase and PFK
were efﬁciently protected against the proteinase K degradation in the
absence of Triton X-100, we feel conﬁdent about the integrity of the or-
ganelles during the assay. Taking all these data together, we conclude
that TbPEX4 is a glycosomal protein associated to the cytosolic face of
the glycosomal membrane. Since this protein does not possess any pre-
dicted transmembrane region, we speculate that it is attached to the
membrane via its interaction with the PEX22 orthologue identiﬁed in
T. brucei, as described in the Supplementary data ﬁle.ction enriched in glycosomal proteins. T. brucei bloodstream-form cells were fractionated by
lular extract, NF: nuclear fraction, LG: large granular fraction, SG: small granular fraction, M:
somal matrix and membrane markers aldolase and TbPEX11. Notice that differential centri-
erable amount of TbPEX4 in theNF. Thehorizontal dashed lines indicatewhere the blotswere
glycosome-rich fractions of an isopycnic density gradient. Glycosomes from T. brucei procyclic
Protein proﬁle in the linear density gradient. B2.Western blot analysis was performed on the
embrane marker TbPEX11, as well as TbPEX4 were used. Additional organelles like the mi-
ate the different parts separately with the respective antisera. (C). GFP-TbPEX4 is present in
ream- (BF) and procyclic-form (PF) cells. Confocal immunomicroscopy was performed using
association with glycosomes. Scale bar: 10 μm.
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To address themolecular function of TbPEX4we have tried as an ini-
tial approach an RNAi-based strategy. However, several attempts each
yielded only clones exhibiting a short, transient reduction of TbPEX4
levels and no growth phenotype. It should be mentioned that in an
RNAi-based high-throughput screening of T. brucei bloodstream and
procyclic forms, it was also found that targeting the mRNA correspond-
ing to TbPEX4 gene (Tb927.8.920) did not cause an effect on growth
[58]. After our unsuccessful RNAi approach,we embarked on a knockout
strategy. In the case of bloodstream-form cells, we never succeeded in
obtaining clones in which both TbPEX4 alleles were replaced since
no cell growth was observed after the second round of selection
with antibiotics. We also tried to create TbPEX4 conditional knockoutPEX4
HXK
C-GAPDH
WT
WT ΔPEX4
PEX4
tubulin
puromycin
blasticidine
-DNA +DNA
PCR
A1
B
Fig. 4. Validation of the ΔPEX4 procyclic T. brucei cell line. Both alleles of the TbPEX4 gene were
ﬁcation of TbPEX4 and antibiotic resistance genes (Puro and Bla) from genomic DNA of the w
methods section). (A2). RT-PCR analysis of cDNA prepared from transcripts of TbPEX4 and anti
see theMaterials andmethods section). (B).Western blot analysis of the TbPEX4protein in cyto
GAPDH, dual cytosolic and glycosomal marker: HXK. Note that the antiserum used for TbPEX4
Thehorizontal dashed lines indicatewhere the blotswere cut to incubate thedifferent parts sepa
both alleles of the TbPEX4 gene and that the encoded protein is absent in the ΔPEX4 cell line.bloodstream-form cells. Unfortunately, clones positive for the three
marker antibiotics, when analysed by Western blot in the absence of
tetracycline, appeared to still express the TbPEX4 protein (data not
shown). Apparently, the second allele had not been efﬁciently replaced,
because gene duplication must have occurred. We infer from this fact
that TbPEX4 might be an important enzyme in the bloodstream form,
causing the cell to adjust the gene copy number when losing the PEX4
gene alleles, similarly as has been observed previously for other genes
in trypanosomes (e.g. [59]). In the case of the procyclic form, several
clones were shown to have lost the TbPEX4 gene and to have acquired
the respective antibiotic resistance genes. This was proved by genomic
PCR, RT-PCR and Western blot. Fig. 4 shows the analysis performed
with the clone used for the phenotypic characterisation described
below.ΔPEX4
70
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WT ΔPEX4 -DNA +DNA
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successfully replaced by the blasticidin and puromycin resistance genes. (A1). PCR ampli-
ild-type (WT) and the ΔPEX4 cell line. (For further explanations, see the Materials and
biotic resistance genes of the wild-type and the ΔPEX4 cell line. (For further explanations,
solic and organellar fractions of wild-type cells and theΔPEX4 cell line. Cytosolicmarker: C-
is an afﬁnity puriﬁed-peptide based antiserum that causes the high background observed.
ratelywith the respective antisera. The three approaches conﬁrm the effective knockout of
3085M. Gualdrón-López et al. / Biochimica et Biophysica Acta 1833 (2013) 3076–30923.5. Absence of TbPEX4 leads to a partial mislocalisation of glycosomal
PTS1-containing matrix proteins and to a mild cell growth defect
A phenotypic characterisation of the TbPEX4 double gene knockout
procyclic cells was performed involving analyses of growth behaviour,
glycosomal matrix protein import and the ubiquitination status of
TbPEX5. The ΔPEX4 cells presented a decreased growth rate when com-
pared with wild-type cells (Fig. 5A). The 2-fold decrease, which was
consistently found in independent experiments, seems not to be very
pronounced, taking into account the essentiality of glycosome biogene-
sis for the viability of the cells as shown in many previous studies
(reviewed by [9,10]). Very interestingly, we observed by phase contrast
microscopy unexpected features with regard to the morphology and
motility of the ΔPEX4 cells. These features concerned a reduced cell
size and a slower displacement of the cells in culture. In order to gain in-
sight into this morphological defect, scanning electron microscopy of
the ΔPEX4 cells was performed. A large part of the cell population
presented an aberrant cell shape with a shorter and wider cell body
compared to the characteristic elongated-thin shape of normal procyclic5
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Fig. 5. Growth behaviour and cellular morphology is affected in the ΔPEX4 cell line. (A). Growt
SDM79 medium. ΔPEX4 cells were shown to have a lower growth rate (by a factor 2) compar
procyclic-form cells. 100% of the wild-type cells presented a typical elongated thin shape (pan
approximately 85% of the cells (panels 2 and 4) presented an aberrant cell-shape (shorter cell b
mal morphology (not shown). Cells in panels 3 and 4 show two ﬂagella indicating cell divisiontrypanosomes (Fig. 5B). To quantify this morphology defect, the
projected area of the cell bodywas determined for 30 cells of each sam-
ple. The results are presented in Table S2. The mean area of projections
of ΔPEX4 cells was only 69% of that of wild-type cells. This cell size dif-
ference was shown to be extremely signiﬁcant (p b 0.001) upon apply-
ing a “Kolmogorov–Smirnov Two Sample Statistical Test”. In an attempt
to obtain, at least by rough approximation, evidence for the defect in the
motility of theΔPEX4 cells, their displacement in culture wasmeasured.
We performed time-lapse image capturing of procyclic wild-type and
ΔPEX4 cells in culture and analysed the changes in the position of indi-
vidual random cells. Table S3 presents the measured distance (μm) and
velocity (μm/s). It was interesting to see a great variability in the speed
between cells of the wild-type culture, indicating that, in general,
procyclic trypanosomes are able to swim in liquid cultures both slow
and fast. Nevertheless, we found that a higher proportion of cells in
the ΔPEX4 culture had a lower motility, making effective displacement
less frequent than observed for wild-type cells. Note that transmission
electron microscopy has been used previously to study mutant T. brucei
cell lines inwhich other peroxins involved in glycosomalmatrix protein60 80 100
urs)
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ed to wild-type cells. (B). Scanning electron-microscopy of T. bruceiwild-type and ΔPEX4
els 1 and 3). Procyclic ΔPEX4 trypanosomes formed a heterogeneous population in which
ody and reduced cellular size). About 15% of the trypanosomes displayed an apparent nor-
.
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changes were also observed in these RNAi mutants: an altered shape,
apoptotic bodies and lysed cells. However, no speciﬁc comparison of
this phenotype with that observed for the ΔPEX4 cells can be made
with the currently available data due to the different microscopy tech-
niques used.
Todetermine if glycosomal protein importwas affected in theΔPEX4
cells wild-type and ΔPEX4 cell lines were created that express GFP
with the C-terminal PTS1 motif SKL (GFP-PTS1) under the control of
a tetracycline-inducible promoter. The correct glycosomal localisation of
the expressedGFP-PTS1 proteinwas then comparedwith the endogenousgGAPDH
GFP-PTS1
DAPI
Merge
gGAPDH
GFP-PTS1
DAPI
Merge
Fig. 6. PTS1 proteins are partiallymislocalised in theΔPEX4 cell line.Wild-type andΔPEX4GFP-P
gGAPDH (a PTS1 containing protein). The colocalisation of the GFP-PTS1 protein with the glyco
GFP-PTS1 colocalised perfectly with the glycosomal marker gGAPDH inwild-type cells, validati
in T. brucei. Although in the ΔPEX4 cells all gGAPDH-stained glycosomes also contain GFP-PTS1glycosomal enzyme gGAPDH (a PTS1 containing protein) by confocal
ﬂuorescence immunomicroscopy. Fig. 6 shows a representative image
of the results obtained. In wild-type as well as in ΔPEX4 cells, the
colocalisation of GFP positive signals with the immunostained gGAPDH
in puncta is evident, conﬁrming its glycosomal localisation and validat-
ing our system for studying glycosomal protein import using GFP-PTS1.
In addition to the ﬂuorescent glycosomes containing the GFP-PTS1 pro-
tein, a ﬂuorescent shadow-like signal throughout the cell bodywas also
observed in the ΔPEX4 cells, but which was absent in wild-type try-
panosomes. Although this cytosolic staining was not prominent, it
might represent a partial mislocalisation, indicative of a minor defectPhase-Merge
Phase
Phase-Merge
Phase
PFWT
PFΔPEX4
TS1 expressing cells were ﬁxed, permeabilised and immunolabelledwith an antiserum for
somal matrix marker was studied by confocal ﬂuorescence microscopy. It was found that,
ng the use of GFP-PTS1 expression as a newmeans for studying glycosomal protein import
, a partial mislocalisation to the cytosol was observed as well. Scale bar 10 μm.
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ing the GFP-PTS1 localisation with the glycolytic enzyme TPI (not
shown).
In spite of the good colocalisation of the two PTS1 containing pro-
teins, a very intriguing observation came from images of the wild-type
cells; some cells presented only the punctate red pattern coming from
the immunostaining of gGAPDH but not the green ﬂuorescence by the
expressed GFP-PTS1 protein. More striking was the fact that some
cells presented, besides glycosomes in which both signals merged,
also puncta in which either one or the other ﬂuorescent label was
present (Fig. 6). This observation might suggest that the population of
glycosomes within a single trypanosome is heterogeneous with regard
to their protein content, a notion that deserves future study.
To determine, at themolecular level, if theΔPEX4 cell linewas affected
in its TbPEX5 recycling, the receptor's ubiquitination was analysed using
the same strategy as established for the study of this modiﬁcation in
wild-type cells (see above and Fig. 1). Fig. 7 shows that, in the ΔPEX4
cell line, TbPEX5 is an equally abundant cytosolic protein as in wild-
type cells and in cells expressing myc-ubiquitin. No signiﬁcant changes
were observed in the steady-state levels of the protein in the cytosol or
in the organellar fraction of the mutant cells when compared to wild-
type and myc-ubiquitin cells, indicating no important accumulation in
the glycosomal membrane. Importantly, the intensity of the slower mi-
grating form of TbPEX5 in wild-type cells, which corresponds to the
ubiquitinated form as demonstrated above, was considerably decreased
in the cytosol of the ΔPEX4 cell line to barely detectable levels and did
not show accumulation in the organellar fraction. This result clearlyenolase
aldolase
PEX5
MycUb-PEX5
Ub-PEX5
PEX5
+DTT
aldolase
enolase
*
Fig. 7. TbPEX5 ubiquitination is impaired in the ΔPEX4 cell line. Cytosolic and organellar fractio
centration of digitonin in thepresence of 20 mMNEM.Western blot analysis shows an importan
functions as a ubiquitin-conjugating enzyme involved in TbPEX5ubiquitination inwild-type cell
neither in the organellar fraction. The * indicates an in vitro proteolytically processed form of T
ferent parts separately with the respective antisera.shows that the protein identiﬁed as TbPEX4 plays a role in this form of
TbPEX5 ubiquitination. In several yeast species, the absence of PEX4
leads to the polyubiquitination of PEX5 at the organellar fractions, an
event that occurs in a UBC4-dependent manner [35–37,60]. Our results
show that in T. brucei the deletion of PEX4 did not cause the accumulation
of such higher molecular weight forms that could correspond to
polyubiquitinated PEX5 (Fig. 7). The abundance of the ubiquitinated
form of TbPEX5 was not affected by the presence of DTT in the protein
preparation. However, as mentioned before, further investigation will be
required to obtain unambiguous proof for a lysine-linked ubiquitination.
The fact that in the complete absence of TbPEX4, TbPEX5
ubiquitination was strongly impaired but not totally abolished
and that the glycosomal protein import process and cell growth were
only mildly affected, raised the question whether there could be a re-
dundancy in the cellular ubiquitination machinery that still allowed
TbPEX5 recycling to occur in ΔPEX4 cells. To investigate this possibility,
themRNA levels of other putative ubiquitin-conjugating (UBC) proteins
were analysed by qPCR inwild-type andΔPEX4 procyclic cells. From the
15 UBC genes identiﬁed in the T. brucei genome database, 10 were se-
lected for these qPCR studies, based on their having the highest degree
of sequence similarity and most similar predicted molecular weight to
TbPEX4 (Table S4). The results obtained showed consistently that four
different putative UBCmRNAswere overexpressed, in a statistically sig-
niﬁcant manner, in the ΔPEX4 cell line (Fig. 8). Interestingly, two of
them have been predicted to possess a PTS1 motif [61], implying that
a glycosomal association is likely, although within the matrix. These
UBCs might be candidates for at least partially functionally replacing-DTT
Cytosol
Organelles
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ns were obtained by selective permeabilisation of the plasma membrane with a low con-
t decrease in the level of theUb-TbPEX5 form in theΔPEX4 cell line, indicating that TbPEX4
s.No important changes in the steady-state levels of TbPEX5were observed in the cytosolic
bPEX5. The horizontal dashed lines indicate where the blots were cut to incubate the dif-
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Fig. 8. Expression levels of genes coding for putative T. brucei ubiquitin-conjugating (UBC)
enzymes in theΔPEX4 cell line. Total RNA from three independent biological samples was
extracted and used to synthesise cDNA. qPCR analysis ofwild-type cells and theΔPEX4 cell
line was performed on three technical replicates and mRNA expression levels of 10 puta-
tive UBC proteins were compared. mRNA abundance was normalised to tubulin and data
were analysed for statistical relevance via a Student's t-test (homoscedasticwith 2 tail dis-
tribution): *p b 0.1, **p b 0.01, ***p b 0.001. Error bars represent the relative standard
error.
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authentic function, a preliminary reciprocal BLAST analysis was
performed for those UBC enzymes that are overexpressed in the
T. brucei ΔPEX4 cell line, querying them against the S. cerevisiae and
human genomes. The results of this analysis are presented in Table S4.
The yeast and/or human orthologues of some of these overexpressed
UBC enzymes have a function in cell-cycle regulation. As will be argued
in the Discussion section, it is conceivable that increased expression of
one or several of these proteins is responsible for partially rescuing
the phenotype of the PEX4 knockout cells, while also causing the addi-
tional phenotypic features. Although this issue is beyond the scope of
the TbPEX5 ubiquitination analysis presented in this paper, the intrigu-
ing, suggestive results warrant further investigation of the rescue possi-
bility in the future.
All these data together conﬁrm that both alleles of the TbPEX4 gene
were successfully knocked out in procyclic cells. We hypothesise that
the conditions established for preparing the knockout in this cell line
have triggered compensatory/adaptivemechanisms inwhich the expres-
sion of other UBC enzymes was signiﬁcantly upregulated above wild-
type levels. This has allowed, at least partially, the rescue of glycosomal
protein import and the survival of the cells, but could also have been re-
sponsible for the aberrant phenotype by affecting other cellular process-
es, thus causing the defects in shape, size and cellular motility.
4. Discussion
In this paper, we have addressed an essential aspect of the
glycosomalmatrix protein import in T. brucei: the recycling of thematrix
protein receptor TbPEX5.We have proved that TbPEX5 is a cytosolic pro-
tein that also interacts with organellar fractions containing glycosomes.
The receptor becomes ubiquitinated, like its fungal and mammalian ho-
mologues, indicating that the principle of the mechanism by which it is
recycled has been conserved throughout eukaryotic evolution, because
trypanosomatids belong to the phylogenetic supergroup of the Excavata,
whereas yeasts and mammals are part of the supergroup Opisthokonta.
The common origin of these and other supergroups has been traced
back to the so-called LECA or last eukaryotic common ancestor which
must have possessed already a peroxisome [8].
Despite these common features, the data obtained in our research
collectively indicate that the TbPEX5 recycling process exhibits also im-
portant differences compared to that of other organisms. Part of TbPEX5was found to be ubiquitinated in both bloodstream and procyclic wild-
type trypanosomes (Fig. 1A). Thismodiﬁcationwas always detected ex-
clusively in the cytosolic fractions after cellular fractionation. A minor
amount of only unmodiﬁed native TbPEX5 was detected at steady-
state levels in the glycosomal membrane, similar to what has been re-
ported for PEX5 in mammalian cells (only about 10% of total PEX5)
[41], implying that in wild-type conditions, the protein is efﬁciently
retrieved to the cytosol after matrix-protein import. The PEX5
ubiquitination machinery of T. brucei is, as in other organisms, present
at the membrane of the organelle, proving that this modiﬁcation must
occur at this cellular location. However, we did not ﬁnd conditions
allowing for the detection of membrane-bound receptor trapped in
the recycling stage with any ubiquitin molecules attached by Western
blot analysis of wild-type cells. This might indicate that in T. brucei the
ubiquitination and subsequent export of TbPEX5 occur as a concerted
fast process. For yeast peroxisomes, it has been reported that a minor
fraction of the membrane-bound PEX5 is ubiquitinated [27]. The fact
that in trypanosomes ubiquitinated PEX5was only detectable in the cy-
tosol, albeit as a minor fraction of the total TbPEX5, seems to reﬂect an-
other important difference compared to the S. cerevisiae peroxisomal
protein import, where an AAA+-ATPase-associated ubiquitin hydrolase
is in charge of the de-ubiquitination of the receptor PEX5, immediately
after or during its export to the cytosol [55]. In T. brucei, we demonstrat-
ed that, even in the absence of deubiquitinase inhibitors like NEM, the
ubiquitinated forms of TbPEX5 were stable in the cytosol (Fig. 1B).
This might indicate that the trypanosomal steady-state process is
more similar to that of mammalian cells, where such stable
ubiquitinated forms of PEX5 are also found in the cytosol of CHO and
Fao cells [40,41]. According to the current model of PEX5 recycling in
mammalian cells, the removal of ubiquitin from the receptor occurs in
the cytosol and is required to enable new rounds of protein import
[62]. Indeed, Grou et al. [63] identiﬁed the ubiquitin hydrolase responsi-
ble for the deubiquitination of the cysteine-monoubiquitin of mamma-
lian PEX5. We envisage that the TbPEX5 deubiquitination process must
be regulated similarly as in mammalian cells.
Another intriguing aspect of the TbPEX5 ubiquitination concerns the
residue that is modiﬁed by ubiquitin. In yeast and mammalian cells, the
signal for PEX5 recycling is the monoubiquitination at a conserved cys-
teine residue (Cys6 in S. cerevisiae and Cys11 in mammals) present in
the N-terminal half [29–31]. Our analysis shows that the ubiquitination
occurring on TbPEX5 is not sensitive to reducing agents such as DTT at
25 mM (Fig. 1A and B), indicative of a lysine-linked ubiquitin moiety
rather than modiﬁcation at a cysteine. PEX5 in several species of yeast
is also a target of lysine-linked ubiquitin chains, but this kind of modiﬁ-
cation occurs only when recycling is impaired as in PEX1–PEX6 and
PEX4–PEX22 deletion mutants and is not considered as a physiological
step in the receptor's recycling [35,36]. The lysine-linked PEX5
ubiquitination process in yeast has been associated with
polyubiquitination of non-functional receptors acting as a signal for
their routing to proteasomal degradation. This occurs as a quality con-
trol mechanism in yeast peroxisomal matrix protein import [36]. How-
ever, this seems to be unlikely the case for the apparent Lys-linked
ubiquitin-PEX5 in T. brucei, because i) these molecules, detected in the
cytosol, were stable in wild-type cells and did not accumulate after
inhibition of the proteasome by the inhibitor lactacystin and ii) the
molecular weights of these modiﬁed TbPEX5 forms do not corre-
spond to the conjugation of a considerable number of ubiquitin moi-
eties, they rather correspond with mono- or di-ubiquitination (Fig.
1A and B). These two facts suggest that the detected ubiquitinated
TbPEX5 is an authentic intermediate in the physiological recycling
of the receptor. The cysteine that serves as ubiquitin target in yeast
and mammalian PEX5s has an equivalent in the same region of the
trypanosomal receptor's primary structure (Fig. S1). Whether it is
Cys3 or another residue – Lys or Cys – in TbPEX5 that is modiﬁed
by ubiquitin requires further investigation by methods like site-
directed mutagenesis of the candidate residues.
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conjugating enzyme responsible for the monoubiquitination of PEX5
in yeast and plant cells, and proved its function in the ubiquitination
of TbPEX5. This protein is associated with glycosomes (Fig. 2), where
it is exposed at the cytosolic face of the membrane (Fig. 3), a topology
also presumed for its counterpart in yeast. In spite of the low sequence
identity of the identiﬁed TbPEX4with other PEX4s (Fig. S2), amino acids
of ScPEX4 involved in the interaction with its membrane-anchor pro-
tein ScPEX22 are to considerable extent conserved in the T. brucei
orthologue (Fig. S3), consistent with the probable existence of such an
anchor protein in the trypanosomes. Indeed, a candidate TbPEX22 was
identiﬁed and the modelled TbPEX4–TbPEX22 interface has shown to
be favourable. The predicted interface region of TbPEX22 was proved
to interact with TbPEX4 in a yeast two-hybrid system, supporting its
identity as the anchor protein of TbPEX4 (Fig. S4). It is worth mention-
ing that TbPEX4, like the PEX4s of yeasts and plants, does not possess a
predicted transmembrane region to attach it directly to the glycosomal
or peroxisomalmembrane. Nonetheless, in all our analyses TbPEX4was
consistently found in the organellar fraction after cell fractionation, fur-
ther supporting the notion that it is anchored by binding to another pro-
tein. Only in the differential centrifugation analysis (Fig. 2A) a relatively
large amount of PEX4 was also found in the nuclear fraction. To a lesser
extent also the speciﬁc glycosomal marker aldolase, a matrix protein,
was found in this fraction, but not the glycosomal integral membrane
protein PEX11. The presence of PEX4 and aldolase in thenuclear fraction
is considered an artefact, due to the release of both this peripheralmem-
brane and the soluble protein from respectively the outer surface and
matrix of the glycosomes upon damage of some organelles during
lysis of trypanosomes by grinding, and a non-speciﬁc afﬁnity of the re-
leased proteins for nuclear constituents.
Future studies should conﬁrm the candidate TbPEX22 unambigu-
ously as the membrane-anchor protein of TbPEX4. A very strong sup-
port for the conﬁrmation of our candidate proteins as TbPEX4 and
TbPEX22 was obtained very recently by their identiﬁcation in a proteo-
mic analysis of T. brucei glycosomes (Dr Lucia Guther and Prof. Michael
Ferguson, personal communication).
The function of TbPEX4 was studied by knocking out the two alleles
of the TbPEX4 gene (Fig. 4). This strategy allowed us to prove ﬁrmly its
role in the ubiquitination of TbPEX5 in procyclic forms (Fig. 7). The re-
sults of the phenotypic analysis were however intriguing, since only
minor mislocalisation of glycosomal proteins was found in this mutant
(Fig. 6). In S. cerevisiae cells, the impairment of ubiquitination of PEX5
by the absence of PEX4 led to the mislocalisation of PTS1 proteins in
the cytosol, as a consequence of the inability of the PEX5 receptor to
cycle back to the cytosol, which is evident by its massive accumulation
in the peroxisomal membrane. The peroxisomal import defect in this
mutant severely affected growth in oleate-based media [35–37]. In
other yeast species such as P. pastoris and H. polymorpha, the absence
of the complex PEX4/PEX22 caused a strong reduction in the steady-
state levels of PEX5 and consequently a defect in the peroxisomalmatrix
protein import. Nevertheless, in these latter species the PTS1- and PTS2-
protein import defect is milder than in baker's yeast [64–66]. Our ﬁnd-
ing that even with a large reduction of ubiquitinated PEX5 molecules,
as observed in the ΔPEX4 mutant, glycosomal protein import was still
functional, TbPEX5 did not accumulate in the glycosomal membrane
and growth was only partially slowed down, was surprising. At ﬁrst
sight, these results would suggest that receptor ubiquitination is not
required for proper receptor recycling in trypanosomes, contradicting
the current model of peroxisomal matrix protein import in yeast and
mammalian cells. However, further investigation of the ΔPEX4 mutant
revealed peculiar aspects that may account for this unexpected result.
We observed that upon knockout of both alleles of the TbPEX4 gene in
procyclic cells, several other UBC genes were signiﬁcantly over-
expressed (Fig. 8). This could have occurred as a compensatory mecha-
nism to overcome the TbPEX5 ubiquitination defect. One of these UBC
proteins could have taken over the function of TbPEX4, albeit with lessefﬁciency than TbPEX4 [since a very faint ubiquitinated PEX5 signal
was detected in the ΔPEX4 mutant by Western blot analysis (Fig. 7)],
maintaining the cells' ability to import proteins into their glycosomes.
Such a “redundant” protein should have similar features to TbPEX4 in
order to be able to interact with the E3 ligase present in the glycosomal
membrane. Onemaywonder if it should also be able to interactwith the
anchor protein TbPEX22. However, permanent attachment to themem-
brane may not be mandatory, since in mammalian cells the functional
counterpart of PEX4, UBCH5, is a soluble cytosolic protein.We speculate
that the putative TbPEX4-compensating protein in the trypanosome
probably lacks an orthologue in S. cerevisiae, or at least not one that
shares a similar function as in the trypanosomes, since this compensato-
ry mechanism seems not to have emerged in the S. cerevisiae ΔPEX4
mutants. In contrast, indications for a similar PEX4 rescue have been de-
scribed in a very recent paper about a study of the in vivo ubiquitination
of the P. pastoris PEX20 [38]. By gene knockout, PEX4 was found to be
necessary for the mono- and di-ubiquitination of this coreceptor on
the conserved Cys8, as well as for the polyubiquitination on Lys19. Im-
portantly, when simultaneously with the absence of PEX4 the
proteasome-dependent degradation pathway of PEX20 was inactivated
by mutation of Lys19, a single ubiquitin moiety was added to both Cys8
(via a DTT sensitive linkage) and, with much lower efﬁciency, in a DTT-
resistant manner to another site of PEX20. This indicates that another,
redundant UBC can substitute for the loss of PEX4 activity. Notably,
the authors could exclude UBC4 as a candidate for the PEX4 redundancy
[38]. These ﬁndings for P. pastoris indicate the realistic nature of our hy-
pothesis that a similar event could have been possible in the T. brucei
ΔPEX4mutant.
Making a nullmutant by knocking out both alleles of the PEX4 gene in
procyclic-form T. brucei generated cells with an approximately two-fold
increase in their duplication time. Despite the impaired ubiquitination of
the glycosomal matrix-protein receptor TbPEX5, protein import
appeared not to be signiﬁcantly affected, leading only to a minor
mislocalisation of PTS1- (Fig. 6) and I-PTS-proteins (data not shown).
Why then was proliferation so much affected and why were the cell
morphology and motility altered? A possible explanation may be found
in the fact that three of theUBC familymembers that showed signiﬁcant-
ly increased mRNA levels in the mutant (Fig. 8) – Tb09.211.0050,
Tb927.8.6090 and Tb927.2.3720 – are ﬁrm orthologues of proteins in-
volved in the cell-cycle regulation in yeast andmammalian cells. The lat-
ter two, Tb927.8.6090 and Tb927.2.3720, are the respective orthologues
of mammalian UBE2C [67,68] and UBE2S [69,70] which promotemitosis
progression through the targeting of cell-cycle regulatory factors, includ-
ing M- and C-cyclins, for proteasome degradation, thus leading to the
ﬁnal separation of sister chromatids. The ﬁrst one, Tb09.211.0050,
which in T. brucei possesses a PTS1, is the orthologue of UBC13 in yeast
and UBE2N in mammalian cells which are involved in the targeting of
substrates during activation of gene transcription as well as during
DNA repair [71,72]. The yeast UBC13 is also linked to mitotic checkpoint
control by protein–protein interaction [73]. We can imagine that
overexpression of one or more UBC genes coding for such functions in
the ΔPEX4 cell line might disturb the ubiquitination – and thus the
functioning – of proteins with a regulatory role in cell cycle control.
This may lead to defects in coordination of DNA synthesis, mitosis, cyto-
kinesis or cell-cycle coupled processes such as ﬂagellum development
and thus offers an explanation for the retardation of growth and altered
motility. Moreover, it can also be envisaged that, instead of the usual for-
mation of equally-sized daughter cells, this loss of cell cycle control in the
mutants is responsible for a population of cells that is quite heteroge-
neous with the majority having a reduced cell body and an abnormal
shape, as was observed by scanning electron microscopy (Fig. 5B). Fu-
ture investigation of this phenomenon should be performed to explore
the validity of our hypothesis. Such an investigation may involve com-
bined analyses of the transcriptome, the cell cycle and cytokinesis. This
would require a detailedmorphometric study to quantify allmorpholog-
ical changes observed betweenmutant and wild-type cells and the ratio
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Fig. 9.Model of the import of glycosomalmatrix proteins in Trypanosoma brucei. Matrix protein import is achieved by a process which involves cyclic receptors, here depicted for TbPEX5,
the receptor ofmatrix proteinswith a PTS1motif. Six distinct steps can conceptually be understood: (I) binding of proteinswith a PTS1 to TbPEX5 (and PTS2 to TbPEX7, plus TbPEX7-PTS2-
proteins to TbPEX5). (II) Docking of the receptor–cargo complex to the docking subcomplex (TbPEX13.1, TbPEX13.2, TbPEX14) in the glycosomal membrane, followed by the insertion of
PEX5 into themembrane, forming in conjunctionwith TbPEX14 a transient pore. (III) Release of PTS proteins, via the transient pore, into thematrix. (IV) Ubiquitination of themembrane-
inserted TbPEX5 by the coordinated action of a cytosolic ubiquitin-conjugating enzyme, TbPEX4, very likely anchored to the membrane by TbPEX22, and an ubiquitin-ligating enzyme of
the RING-ﬁnger subcomplex, which comprises PEX2, PEX10 and PEX12. (V) Fast retrieval of the ubiquitinated PEX5 from themembrane by the cytosolic AAA+-ATPase complex including
PEX1 and PEX6, recruited to the membrane. (VI) Deubiquitination of PEX5, rendering the receptor available to mediate new rounds of PTS-protein import. All peroxins identiﬁed in
T. brucei are indicated in this scheme by the numbers attributed previously to their S. cerevisiae homologues.
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population.
In conclusion, our research on themolecularmechanism involved in
the recycling of TbPEX5, together with previous work done by us and
others, led us to adjust the model for glycosomal protein import in
T. brucei (Fig. 9): TbPEX5 is a cytosolic protein that recognises PTS1 pro-
teins and participates in their import, as well as mediates PTS2 protein
import through its interaction with the PTS2 receptor TbPEX7. The
cargo-loaded PTS1 receptor docks at the peroxisomal membrane by
interacting, through its N-terminal domain, with peroxins TbPEX13.1,
TbPEX13.2 and TbPEX14. The translocation of the cargo probably occurs
similarly as shown in S. cerevisiae cells, by the formation of a dynamic
and transient pore formed by the receptor TbPEX5 and probably
TbPEX14. After the cargo release, the receptor TbPEX5 is ubiquitinated,
by the glycosomal E2 enzyme TbPEX4 in concert with the activity of the
E3 RING-ﬁnger complex (very likely TbPEX12) and then rapidly
exported to the cytosol by the action of the TbPEX6/TbPEX1. The
ubiquitinated TbPEX5 is stable in the cytosol. The signalling ubiquitin
is probably removed by an (enzymatic/or chemical)mechanismhomol-
ogous to the one in mammalian cells but that operates at a much lower
steady-state level.Acknowledgements
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